首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2903899篇
  免费   238577篇
  国内免费   6657篇
耳鼻咽喉   42826篇
儿科学   88517篇
妇产科学   78596篇
基础医学   410925篇
口腔科学   84406篇
临床医学   264081篇
内科学   563254篇
皮肤病学   58907篇
神经病学   243681篇
特种医学   116547篇
外国民族医学   1053篇
外科学   441690篇
综合类   74839篇
现状与发展   6篇
一般理论   1170篇
预防医学   234519篇
眼科学   69795篇
药学   217544篇
  16篇
中国医学   6159篇
肿瘤学   150602篇
  2018年   29118篇
  2016年   24937篇
  2015年   28490篇
  2014年   41016篇
  2013年   62064篇
  2012年   83689篇
  2011年   88289篇
  2010年   51962篇
  2009年   49649篇
  2008年   83433篇
  2007年   89291篇
  2006年   89891篇
  2005年   87792篇
  2004年   84740篇
  2003年   81860篇
  2002年   80534篇
  2001年   130263篇
  2000年   134776篇
  1999年   114236篇
  1998年   33710篇
  1997年   30781篇
  1996年   30316篇
  1995年   29321篇
  1994年   27579篇
  1993年   25666篇
  1992年   93109篇
  1991年   89840篇
  1990年   86944篇
  1989年   83761篇
  1988年   78056篇
  1987年   77069篇
  1986年   72897篇
  1985年   69972篇
  1984年   53457篇
  1983年   45720篇
  1982年   28238篇
  1981年   25251篇
  1980年   23767篇
  1979年   51276篇
  1978年   36323篇
  1977年   30596篇
  1976年   28595篇
  1975年   30329篇
  1974年   37518篇
  1973年   35866篇
  1972年   33635篇
  1971年   31077篇
  1970年   29400篇
  1969年   27644篇
  1968年   25148篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.

Objectives

Expedient extubation after cardiac surgery has been associated with improved outcomes, leading to postoperative extubation frequently during overnight hours. However, recent evidence in a mixed medical-surgical intensive care unit population demonstrated worse outcomes with overnight extubation. This study investigated the impact of overnight extubation in a statewide, multicenter Society of Thoracic Surgeons database.

Methods

Records from 39,812 patients undergoing coronary artery bypass grafting or valve operations (2008-2016) and extubated within 24 hours were stratified according to extubation time between 06:00 and 18:00 (day) or between 18:00 and 6:00 (overnight). Outcomes including reintubation, mortality, and composite morbidity-mortality were evaluated using hierarchical regression models adjusted for Society of Thoracic Surgeons predictive risk scores. To further analyze extubation during the night, a subanalysis stratified patients into 3 groups: 06:00 to 18:00, 18:00 to 24:00, and 24:00 to 06:00.

Results

A total of 20,758 patients were extubated overnight (52.1%) and were slightly older (median age 66 vs 65 years, P < .001) with a longer duration of ventilation (4 vs 7 hours, P < .001). Day and overnight extubation were associated with equivalent operative mortality (1.7% vs 1.7%, P = .880), reintubation (3.7% vs 3.4%, P = .141), and composite morbidity-mortality (8.2% vs 8.0%, P = .314). After risk adjustment, overnight extubation was not associated with any difference in reintubation, mortality, or composite morbidity-mortality. On subanalysis, those extubated between 24:00 and 06:00 exhibited increased composite morbidity-mortality (odds ratio, 1.18; P = .001) but no difference in reintubation or mortality.

Conclusions

Extubation overnight was not associated with increased mortality or reintubation. These results suggest that in the appropriate clinical setting, it is safe to routinely extubate cardiac surgery patients overnight.  相似文献   
52.
53.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
54.
55.
56.
57.
58.
59.
60.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号